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Although transcriptional regulation of stem cell
pluripotency and differentiation has been extensively
studied, only a small number of studies have ad-
dressed the roles for posttranslational modifications
in these processes. A key mechanism of posttransla-
tional modification is ubiquitination by the ubiquitin-
proteasome system (UPS). Here, using shotgun pro-
teomics, wemap the ubiquitinated protein landscape
during embryonic stem cell (ESC) differentiation
and induced pluripotency. Moreover, using UPS-
targeted RNAi screens, we identify additional regula-
tors of pluripotency and differentiation. We focus on
two of these proteins, the deubiquitinating enzyme
Psmd14 and the E3 ligase Fbxw7, and characterize
their importance in ESC pluripotency and cellular
reprogramming. This global characterization of the
UPS as a key regulator of stem cell pluripotency
opens the way for future studies that focus on
specific UPS enzymes or ubiquitinated substrates.
INTRODUCTION
It is well established that embryonic stem cell (ESC) self-renewal
and differentiation are regulated by a network of transcription
factors including Oct4, Nanog, and Sox2; in addition, Sox2 and
Oct4 are also key factors in cellular reprogramming (Avilion et al.,
2003; Chambers et al., 2003; Nichols et al., 1998). Additional
levels of ESC-specific regulation have been characterized,
including important roles for environmental cues, epigenetic
regulators, and microRNAs (miRNAs) (Martinez and Gregory,
2010; Meissner, 2010; Wang et al., 2007; Ying et al., 2003).
Recent studies suggested that transcription-independent regu-
lation of proteins can also control ESC fates (Lu et al., 2009);
however, there is limited information on the role of posttransla-Celltional modifications in ESC differentiation and function. Although
studies have addressed the role of phosphorylation (Li et al.,
2011; Phanstiel et al., 2011), the role of protein turnover by the
ubiquitin-proteasome system (UPS) has not yet been explored.
The relative abundance and other functional modifications of
proteins are regulated by a complex cellular machine, the UPS,
that specifically adds or removes ubiquitin to proteins (Pickart,
2001). The specificity of the reaction is provided by the E3 ligase
complex, which conjugates activated ubiquitin to the substrate.
Repetition of this action ensures polyubiquitination and leads to
recognition by the 26S proteasome, followed by proteolysis. On
the other hand, monoubiquitinated proteins have nonproteolytic
fates. Moreover, apart from the function of distinct ligase com-
plexes, the UPS is also regulated by a class of deubiquitinating
enzymes (DUBs) responsible for removing ubiquitin conjugates
from substrates (Kimura and Tanaka, 2010). The study of UPS-
mediated regulation of stem cell function has been recently intro-
duced by studies of hematopoietic stem cell differentiation. Our
laboratory and others have identified the F box E3 ligase Fbxw7
as a key component of hematopoietic and neural stem cell self-
renewal and differentiation (Matsumoto et al., 2011; Matsuoka
et al., 2008; Reavie et al., 2010; Thompson et al., 2008). Little
is known about the function of UPS components in pluripotency.
It has been suggested that the proteasome is important in
sequestering transcription factor binding to regulatory regions
of genes necessary for development, modulating their gene
expression (Szutorisz et al., 2006). It was also suggested that
some pluripotency regulators are ubiquitinated. However, the
roles and significance of such modifications remain unclear
(Gontan et al., 2012; Liao and Jin, 2010; Ramakrishna et al.,
2011).
To study the role of the UPS in ESC pluripotency and cellular
reprogramming, we employed a combination of genomic and
proteomic approaches. Initially, we applied quantitative mass
spectrometry to map the global changes in protein expression
and ubiquitination in pluripotent and differentiated ESCs and
showed that a significant number of the members of the core
pluripotency machinery are modified by ubiquitin. Second, weStem Cell 11, 783–798, December 7, 2012 ª2012 Elsevier Inc. 783
Figure 1. Mapping of the Mouse ESC Ubiproteome
(A) Scheme depicting the proteomic strategy followed using SILAC and MS/MS technology. mESC, murine ESC.
(B) Ingenuity Pathways-generated network with Nanog and Oct4 as nodes. Molecules in red show a higher ubiquitination rate in self-renewal conditions, and
those in green shower a higher rate in differentiated cells. Color intensities reflect ubiquitination detection values. White marks molecules that belong to the
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members of the UPS, and identified a significant number of
putative novel regulators. Finally, we confirmed the role of
selected UPS members in regulating pluripotency of ESCs. For
example, in the current study, we showed that silencing of
Fbxw7 expression inhibits ESC differentiation and enhances
cellular reprogramming through stabilization of c-Myc. Further-
more, we demonstrated that the DUB Psmd14 is essential for
cellular reprogramming and maintenance of ESC self-renewal
because of its enzymatic activity within the proteasome lid.
Finally, we directly compared the ‘‘ubiproteome’’ of ESCs and
induced pluripotent stem cells (iPSCs) and demonstrated
a remarkable similarity of ubiquitin modifications in these two
cell types. These studies map protein ubiquination in ESC
pluripotentcy, differentiation, and cellular reprogramming, intro-
ducing an additional level of regulation of these processes.
RESULTS
Mapping the Ubiquitin-Modified Proteome during ESC
Differentiation
To quantitatively assess ubiquitin-modified proteins in pluripo-
tent and differentiated mouse ESCs (Figure 1A; Figure S1 avail-
able online), we labeled pluripotent ESCs with stable-isotope
amino acids in cell culture (SILAC). For direct comparison to
differentiated cell populations, cells were maintained in light
medium and differentiated for 4 days. We then mixed equal
amount of labeled (heavy) and unlabeled lysates, digested the
mixed lysate with trypsin, and enriched for ubiquitin-modified
peptides using an affinity matrix coupled with diglycine (diGly)-
modified lysine antibodies (Kim et al., 2011; Xu et al., 2010).
We analyzed the enriched peptides by liquid chromatography-
tandem mass spectrometry (LC-MS/MS) (Figure 1A). We
identified 2,578 nonredundant ubiquitin-modified peptides with
a false discovery rate of 1%, which were assigned to 1,168
unique proteins (Table S1). We repeated these experiments
using label-free detection to increase the efficiency of identi-
fication of ubiquitin-modified peptides (Table S1). We found
a significant concordance between these two approaches,
made especially evident by the identification of ubiquitin-modi-
fied peptides from well-characterized members of the extended
pluripotency network (Figure 1B; Table S2).
To understand the biological significance of the identified
ubiquitin-modified proteins, we classified these proteins using
the Ingenuity Systems Pathway Analysis (IPA) software and
created a pluripotency network centered around the ubiquiti-
nated key regulators Nanog and Oct4. In pluripotent ESCs, we
detected a significant number of ubiquitin-modified proteins
that are key regulators of self-renewal in ESCs (Figures 1B and
S1). Notably, we were also able to identify novel sites of ubiquiti-
nation (Figure S1). We focused on ubiquitin-modified peptides
representing proteins more highly detected in the pluripotent
or in the differentiated ESCs. (Figure 1C; Table S1). DAVID func-network and were not detected in our study. Orange marks pluripotency fact
‘‘binding.’’ Lines with arrows mean ‘‘acting on.’’ Dotted lines reflect an indirect in
(C) Heat map illustrating fold change of ubiquitinated peptides differentially dete
(D) Venn diagram showing the overlap between the mouse phospho-proteome (L
underlined in the pluripotency network in dark gray.
Celltional annotation (Huang et al., 2009) revealed enrichment
of distinct biological classifications in both populations. The
pluripotency-associated ubiquitin-modified proteins included
several known pluripotency factors (e.g., Nanog, Oct4, Dax1,
and Rex1), epigenetic factors (e.g., Jarid2, Kdm3a, and
Hdac1), and translation-related proteins (e.g., eEF1A1 and
Rps10). In contrast, in the differentiated-associated ubiquitin-
modified proteins we detected proteins involved in retinoic
acid metabolism (e.g., CYP26a and STRA8), protein scaffolding,
and cell adhesion (Figure S2).
Phosphorylation is the best-studied posttranslational modifi-
cation in ESCs on a proteome-wide scale (Li et al., 2011). Given
that phosphorylation can prime proteins for ubiquitination
(Deshaies and Joazeiro, 2009), we cross-referenced our data-
bases to previously published phosphoproteome studies in
ESCs and identified 289 proteins (19.1%) marked by both phos-
phorylation and ubiquitination (Figure 1D). Interestingly, many of
those proteins are also part of the pluripotency network
shown in Figure 1B (outlined), suggesting a potential crosstalk
between ubiquitination and phosphorylation in the regulation of
pluripotency in ESCs. These studies identified specific ‘‘ubiquitin
signatures’’ for ESC self-renewal and differentiation, strongly
suggesting a connection between ubiquitination and ESC
pluripotency.
UPS-Mediated Protein Half-life of Key Pluripotency
Factors
Because the UPS can control protein half-life and degradation,
we set out to define such UPS-regulated pluripotency and differ-
entiation factors. Using multidimensional protein identification
technology (MudPIT), we identified 5,440 proteins from the
nuclear fraction of pluripotent ESCs in the presence or absence
of the proteasome inhibitor MG132. The fold changes of proteins
with or without the MG132 treatment followed a Gaussian-like
curve, suggesting that MG132 did not cause a systemic change
in protein expression (Figure 2A). Ubiquitin-modified peptides
identified using the diGly-lysine affinity matrix appeared to be
found mostly in proteins with increased levels in the presence
of MG132. From these identified proteins, approximately 25%
(1,311) were found to show a >2-fold increase in expression in
response to MG132, and ubiquitin-modified peptides were
found in 145 of these proteins (Figure 2A; Table S3). Interestingly,
several known stem cell transcription factors such as Nanog,
Rex1, Dax1, or c-Myc were among these ubiquitin-modified
proteins, in both ubiquitinated and stabilized forms. Next, we
verified the ubiquitin modifications found on several pluripo-
tency-associated factors (Figures 2B, 2C, and S3) and confirmed
the stabilization of selected proteins using western blot analysis
(Figure S3). Moreover, we validated polyubiquitination of key
pluripotency factors found ubiquitinated in pluripotent ESCs
(Figures 2C, 2D, and S2). Both Nanog and Oct4 (but not Sox2)
were specifically ubiquitinated in pluripotent cells, suggest-
ing active regulation of their relative protein abundance inors only detected in the label-free experiments. Lines without arrows mean
teraction.
cted in self-renewing ESCs and in differentiated cells.
i et al., 2011) and the ubiproteome obtained in this study. Common proteins are
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Figure 2. Half-life of Key Pluripotency Factors Is Regulated by the UPS
(A) Differential expression of ES nuclear proteins in the presence of MG132. Proteins with increased expression in the presence of MG132 are indicated by an
arrow (>2-fold increase). The x axis shows the ratios of MS/MS spectra identified in the MG132 treatment over the MS/MS spectra identified in the dimethyl
sulfoxide (DMSO) treatment for each protein in the natural logarithm (ln). The y axis shows the number of proteins collectively in each binned ratio.
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hypothesis, we quantified protein half-life at different stages of
differentiation, and we were able to show that both factors
were actively degraded in pluripotent ESCs, but not differenti-
ated ESCs (Figures 2E and 2F). This finding could have important
consequences for the understanding of ESC function, because it
suggests that during pluripotency the UPS is actively restricting
the protein abundance of key regulators such as these.
Identification of UPS Members Essential for the
Maintenance of ESC Self-Renewal
To begin mapping the function of members of the UPS respon-
sible for ubiquitination events identified by our mass-spec-
trometry approach, we targeted the UPS using small interfering
RNA (siRNA)-mediated gene silencing in ESCs. We used siRNA
libraries against E1 activating enzymes, E2 conjugating
enzymes, E3 ligases, deubiquitinating enzymes, and predicted
E3 ligases. siRNA libraries contained a pool of four siRNAs
targeting approximately 640 known and predicted UPS genes.
Following transfection of siRNA, cells were maintained in
cultures supplemented with leukemia inhibitory factor (LIF),
maintaining the pluripotency of ESCs. To monitor loss of self-
renewal, we used a ‘‘knockin’’ reporter ESC line, in which green
fluorescent protein (GFP) expression is driven by the Nanog
regulatory elements (Schaniel et al., 2010) (Figure S4). Nanog-
GFP expression was monitored by flow cytometry. Effects on
differentiation were compared to silencing of known regulators
of self-renewal (Oct4 and Sox2). To identify genes specifically
affecting pluripotency, we eliminated siRNAs that lead to cell
death or cell-cycle deregulation. The initial screen revealed 20
genes that when silenced lead to significant effects on ESC
self-renewal. Genes that were considered hits had >9%differen-
tial expression of GFP compared to the control nontarget siRNA
(differential expression =%GFP cells in target gene%GFP
cells in nontarget control) and had a Z score >1 (Figures 3A, and
S4; Table S3).
To rule out off-target effects and validate the utilized siRNAs,
we screened 13 selected genes by targeting distinct areas of the
transcript. Nine out of the 13 tested genes validated (Figure 3B).
These genes represented DUBs (Psmd14 andUsp9x), E3 ligases
(Rbx1, Rfwd2, Rnf12, Ubr5, and Ddb1), and two putative E3
ligases based on RING-motif homology (Trim28 and Phf5a).
Three selected genes (Psmd14, Ubr5, and Ddb1) were further
evaluated for their role in ESC self-renewal and pluripotency
(Figures 3C and 3D). We then performed assays to determine
the role of these selected genes in ESC identity. Knockdown of
all three selected genes lead to a >50% decrease in the expres-
sion of the known pluripotency genes, Nanog, Oct4, and Zfp42
(Figure 3E). On the other hand, genes associated with early
ESCdifferentiation to distinct lineages showedmarked (although
heterogeneous) increases in expression (Figure 3E). The knock-
down of all three genes showed moderate induction of early(B) Representative annotated MS/MS spectra of the Oct4- and c-Myc-remnant-c
sequence of the ubiquitinated peptide and the diGly-modified lysine (K*) are indi
(C) In vivo ubiquitination experiments of pluripotency factors in self-renewing co
(D) In vivo ubiquitination of Nanog, Oct4, and Sox2 in self-renewal and 24 hr of d
(E) Western blot analysis of Nanog, Oct4, Sox2, and Cullin1 half-life in self-renew
(F) Quantification of the half-life of proteins depicted in (E). Plots represent norm
Cellmesoderm markers (Meox1 and Mixtl1); however, early ecto-
derm (Nk2.2 and Fgf5) and endoderm (Gata6 and Sox17) genes
showed significant increases in gene expression (Figure 3E). To
further support these initial expression studies, we used whole-
transcriptome profiling. This analysis revealed a homogenous
downregulation of ESC pluripotency-associated gene expres-
sion and concomitant activation of genes associated with early
differentiation (Figure 3F). Although we observed a homogenous
downregulation of pluripotency genes, global expression pro-
filing revealed that each siRNA had a unique set of differentially
expressed genes, suggesting a unique role in inhibiting specific
lineage commitment (Figure S4). Immunofluorescence studies
showed that in response to siRNA-mediated knockdown of
Psmd14, Ddb1, and Ubr5, ESCs had significant loss of Oct4
protein expression coupled to morphology changes, similar to
ESCs lacking Sox2 (Figure 3G). These combined studies identify
UPSmembers playing roles in the regulation of ESC self-renewal
and highlight Psmd14, Ddb1, and Ubr5 as regulators of ESC
pluripotency.
Identification of UPS Members Essential for the
Regulation of ESC Differentiation
To study the influence of members of the UPS on early ESC
differentiation, we repeated our UPS-targeted siRNA screen,
but this time we forced ESC differentiation by LIF withdrawal
and addition of retinoic acid (RA). As a ‘‘positive’’ control for
known factors affecting ESC differentiation, we used siRNA
oligos against Sox17 (Niakan et al., 2010). Putative ‘‘hits’’ were
defined as previously described. We identified 17 genes that,
when their expression was silenced, led to significant upregula-
tion of Nanog-GFP expression (Figures 4A and S5; Table S5). To
validate siRNAs, we selected ten genes to screen using four
individual siRNAs distinct from the ones contained in the screen
library. Knockdown of nine out of ten genes lead to a significant
maintenance of Nanog-GFP expression when targeted with at
least two siRNAs (Figure 4B). These genes included six E3
ligases (Fbxw7, Rnf152, Rnf31, Rnf8, Socs3, and Topors), two
putative ligases based on ubiquitin-like domain analysis and
conservation (Rnf36 and Tnfrsf25), and Ubl5, an ubiquitin-like
protein (Figure 4B).
Three of the validated genes (Fbxw7, Socs3, and Rnf31) were
selected for further functional characterization (Figures 4C, 4D,
and S5). Socs3 and Rnf31 showed an increase of RNA transcript
levels in days 2 and 4 of differentiation when compared to
self-renewing ESCs (Figure S5). Silencing of these selected
candidate genes revealed homogenous upregulation of key
pluripotency genes, including Oct4, Nanog, and Zfp42, whereas
early lineage differentiation genes revealed varied degrees of
downregulation (Figure 4E), reflecting putative specificity for
distinct lineages. To further support this initial expression anal-
ysis, we have used whole-transcriptome analysis in ESCs in
which Fbxw7, Socs3, and Rnf31 expression was silenced.ontaining peptides obtained by immunoprecipitation in pluripotent ESCs. The
cated. m/z, mass-to-charge ratio.
nditions. Ub-IP, immunoprecipitation of ubiquitinated proteins.
ifferentiation with RA using ubiquitin pull-down enrichment.
al and 24 hr of differentiation using 50 mg/ml of cycloheximide.
alized intensity relative to actin.
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Figure 3. UPS-Targeted siRNA Screen Identifies Genes Required for Maintaining ESC Self-Renewal and Pluripotency
Nanog-GFP ESCs were transfected with pools of siRNAs under conditions of self-renewal and analyzed by fluorescence-activated cell sorting (FACS) 48 hr later.
(A) Dot plot representing Z score for all siRNAs.
(B) siRNA pool validation by individual siRNAs.
(C) FACS plots depicting loss of Nanog-GFP following siRNA transfection.
(D) Knockdown efficiency by quantitative RT-PCR (qRT-PCR) after siRNA transfection.
(E) Relative expression of pluripotency genes (Oct4, Nanog, and Zfp42), endoderm genes (Gata6 and Sox17), mesoderm genes (Meox1 and Mixtl1), and
ectoderm genes (Nk2.2 and Fgf5) by qRT-PCR. Data are represented as ± SEM; n = 3. *p value < 0.05; **p value < 0.01.
(F) Heat map illustrating gene expression (log2). Selected pluripotency and differentiation genes are shown.
(G) Immunofluorescence and bright field images 48 hr after siRNA knockdown. Staining for Oct4 (green), Phalloidin (red), and DAPI (blue) is shown.
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Figure 4. UPS-Targeted siRNA Screen Identifies Genes Required for Optimal ESC Differentiation
Nanog-GFP ESCs were transfected with pools of siRNAs and differentiated for 48 hr, followed by FACS analysis.
(A) Dot plot representing Z scores of all siRNAs.
(B) Differential expression of Nanog-GFP compared to nontarget with individual siRNAs.
(C) Histogram FACS plots showing retention of GFP following siRNA transfection.
(D) Relative knockdown after siRNA transfection by qRT-PCR.
(E) Relative expression of pluripotency genes (Oct4, Nanog, and Zfp42), endoderm genes (Gata6 and Sox17), mesoderm genes (Meox1 and Mixtl1), and
ectoderm genes (Nk2.2 and Fgf5) by qRT-PCR. Data are represented as ± SEM; n = 3. *p value < 0.05; **p value < 0.01.
(F) Immunofluorescence and bright-field images 72 hr after siRNA knockdown. Staining for Oct4 (green), Phalloidin (red), and DAPI (blue) is shown.
(G) Heat map illustrating changes in gene expression (log2). Selected pluripotency and differentiation genes are shown.
Cell Stem Cell
Pluripotency Regulated by Ubiquitination
Cell Stem Cell 11, 783–798, December 7, 2012 ª2012 Elsevier Inc. 789
Figure 5. Psmd14, a Component of the 19S Proteasome Lid, Is Required for Optimal ESC Function
(A) Relative expression of Psmd14 mRNA during ESC differentiation with RA.
(B) Downregulation of Psmd14 protein levels in ESCs following differentiation with RA.
(C) Scheme depicting 26S proteasome components and Psmd14-interacting partners. The bait is Psmd14 (purple), and interacting partners are encircled in blue.
(D) Western blots with antibodies against Psmd14, Psmd11, Psmd12, Psmb4, K48- and K63-linkage specific linked, and pan-ubiquitin following Psmd14
knockdown in ESCs.
(E) Immunofluorescence showing K48-ubiquitin accumulation in response to Psmd14 RNAi.
(F) Relative expression of genes following induction of exogenous Psmd14 in ESCs.
(G) Western blot analysis after 4 days of differentiation in the presence or absence of Dox.
(H) Relative expression of pluripotency genes Oct4, Nanog, and Zfp42 (Rex1) and genes representing endoderm (Gata6), mesoderm (T), and ectoderm (Nestin) by
qRT-PCR after 4 days of differentiation in the presence or absence of Dox.
(I) Western blot showing StrepII- and Flag-tagged Psmd14WT, Psmd14H113Q, or Psmd14C120S mutant protein expression in targeted KH2 cells in the presence or
absence of Dox.
Cell Stem Cell
Pluripotency Regulated by Ubiquitination
790 Cell Stem Cell 11, 783–798, December 7, 2012 ª2012 Elsevier Inc.
Cell Stem Cell
Pluripotency Regulated by UbiquitinationGene silencing lead to a homogenous upregulation of genes
related to ESC pluripotency, including Nanog, Zfp42, and Essrb
(Figure 4G). However, overall regulation of differentiation-
specific gene expression was heterogeneous, demonstrating
differential roles of individual genes in inhibition of differentiation
(Figures 4G, and S5). Finally, to gage morphological and protein
expression changes of candidate cell populations in response to
siRNA-mediated silencing, immunofluorescence was performed
(Figure 4F). Consistent with the Nanog-GFP expression changes
in our primary screen, the morphology varied between condi-
tions, although all candidate genes showed more significant
ESC colony-like morphology, and these colonies consisted of
more self-renewing (Oct4-positive) ESCs (Figures 4C and 4F).
These combined studies identified members of the UPS that
play roles in the regulation of ESC differentiation.
Psmd14, a Member of the Proteasome Lid, Is Essential
for ESC Pluripotency
We then decided to focus on selected screen ‘‘hits’’ to better
understand their mechanisms of action. We initially focused on
Psmd14, because it was identified in our RNAi screen as one
of the most potent regulators of ESC pluripotency (Figures 3
and S4). Pluripotent ESCs express significant amounts of
Psmd14, and its expression is downregulated as the cells differ-
entiate, suggesting specific functions associated with pluripo-
tency (Figures 5A and 5B). We sought to identify Psmd14-
interacting partners by generating doxycycline (Dox)-inducible
ESC lines expressing StrepII and Flag tags. Psmd14-interacting
partners were identified using LC-MS/MS. In agreement with
previous studies of the yeast proteasome, Psmd14 was shown
to specifically associate with the majority of the members of
the 19S proteasome lid, including Psmd3, Psmd6, Psmd7,
Psmd11, Psmd12, and Psmd13 (Figure 5C; Table S6) (Lander
et al., 2012). No such peptide was identified in control enhanced
GFP pulldowns, strongly suggesting the specificity of the inter-
action with the proteasome lid.
To start investigating Psmd14 functions, we initially excluded
significant effects on ESC viability (Figure S6). Moreover, we
noticed that upon Psmd14 downregulation, the expression of
its interacting partners and components of the proteasome lid,
Psmd11 and Psmd12, remained unaffected (Figure 5D). Simi-
larly, the protein levels of the core component Psmb4 remained
unaltered, suggesting that the overall stoichiometry of the 26S
proteasome remained unchanged (Lander et al., 2012). Strik-
ingly, we observed that both K48- and K63-polyubiquitinated
proteins accumulated extensively by western blot analysis in
response to Psmd14 downregulation, indicating defective pro-
teasome activity (Figure 5D). Immunofluorescence revealed an
increase in total K48-specific staining in ESCs, which corre-
sponded to loss of Oct4 expression and morphology changes
consistent with ESC differentiation (Figures 3G and 5E). These(J) Western blot analysis with antibodies against Flag (Psmd14), Psmd11, and P
proteins.
(K) Bar graph representing mean fluorescent intensity (MFI) of SSEA1-expressing
of Dox and normalized to nontarget control.
(L) Western blot analysis of Oct4 and K48-linkage specific polyubiquitinated prot
Psmd14WT, Psmd14H113Q, or Psmd14C120 proteins.
Data are represented as ± SEM; n = 3. WT, wild-type. *p value < 0.05; **p value
Cellresults illustrate that Psmd14 is necessary for self-renewal
because of proper deubiquitination and subsequent degradation
of target proteins in ESCs. To further support this hypothesis, we
were able to show that Psmd14 overexpression could inhibit
differentiation as illustrated in Figures 5F, 5G, and S6. In-
terestingly, it appears that Psmd14-interacting proteins at the
proteasome lid could play similar roles. Silencing of the
Psmd14-interacting components Psmd13 and Psmd11 induced
a significant loss of Nanog-GFP expression, and both are down-
regulated during ESC differentiation (Figure S6), suggesting
a more global proteasome-lid response during differentiation.
The DUB Enzymatic Activity of Psmd14 Is Essential
for ESC Pluripotency
Psmd14 contains a JAMM/MPN+ motif sequence, and its cata-
lytic site resembles that of a zinc metalloprotease (Verma et al.,
2002; Yao and Cohen, 2002). Two conserved histidines among
different species from yeast to human, H113 and H115, are
thought to play a key role in coordinating the zinc ion. To deter-
mine the role of the enzymatic activity of Psmd14 and exclude
the possibility that the RNAi-induced effects are solely attribut-
able to the structural requirement for Psmd14, we generated
inducible ESC lines expressing point mutants on the MPN+
domain (Figures 5I and S6). Proper incorporation of mutant
proteins into the proteasome lid (Gallery et al., 2007) was verified
(Figure 5J).
Knockdown of the endogenous Psmd14 transcripts was
achieved using short hairpins that target the 50 or the 30 un-
translated region. Induced expression of the Psmd14WT,
Psmd14H113Q, or Psmd14C120S coding region was utilized in
order to investigate possible rescue of the differentiation pheno-
type. We observed that Psmd14WT-expressing ESCs were resis-
tant to knockdown, as measured by SSEA1 staining of trans-
duced cells. In contrast, the point mutant Psmd14H113Q failed
to rescue the RNAi-induced phenotype. However, similarly to
Psmd14WT, Psmd14C120S-expressing cells were able to revert
the differentiation phenotype measured by SSEA1 levels (Fig-
ure 5K). Moreover, the Psmd14WT- and Psmd14C120S-express-
ing cells retain elevated levels of Oct4 compared to uninduced
cells after small hairpin RNA (shRNA) Psmd14 knockdown, but
Psmd14H113Q-expressing ESCs did not (Figure 5L). In agreement
with the above, only Psmd14- and Psmd14C120S-expressing
ESCs, but not Psmd14H113Q-expressing ESCs, were able to
retain alkaline phosphatase (AP) activity after 4 days of differen-
tiation with RA and under constant induction (Figure S6). Further-
more, western blots for K48- or K63-specific antibodies showed
a marked decrease in both types of polyubiquitinated proteins
following induction of Psmd14WT and Psmd14C120S, but not
Psmd14H113Q expression, indicating proper deubiquitinating
activity that allows for efficient proteasome function (Figures
5L and S6). The above combined results suggest that thesmd12 antibodies following elutions of StrepII-purified Flag-tagged Psmd14
cells following shRNA transfection against Psmd14 in the presence or absence
eins in ESCs following knockdown of endogenous Psmd14 and expression of
< 0.01.
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Figure 6. Fbxw7 Targets c-Myc for Degradation during ESC Differentiation
(A) Western blot of pluripotency factors following Fbxw7 silencing in day 0 and 2 of differentiation.
(B) Cotransfection of Fbxw7 and pluripotency factors in 293T cells followed by immunoprecipitation (IP). Lanes 1 and 2, whole-cell extract; lanes 3 and 4,
immunoprecipitates.
(C) qRT-PCR of Fbxw7 and c-Myc during differentiation.
(D) c-Myc protein expression during differentiation with or without 10 mM MG132 treatment.
(E) Immunoblot of known Fbxw7 substrates at days 0 and 2 of differentiation.
(F) Intracellular FACS staining profiles for c-Myc protein levels following shRNA transduction and ESC differentiation with RA for 2 days.
(G) Comparison of c-Myc protein levels with intracellular FACS staining on day 2 of differentiation following knockdown of Fbxw7.
(H) Histogram representing retention of GFP 72 hr after siRNA transfection and 48 hr after addition of differentiation media. Bar graph on the right represents MFI
of ESCs in one representative experiment (n = 3).
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proper ESC identity.
The E3 Ligase Fbxw7 Controls ESC Pluripotency by
Regulating c-Myc Protein Stability
We then focused on the molecular function of Fbxw7, which,
when silenced, leads to an inhibition of ESC differentiation. We
initially determined whether inhibition of differentiation following
Fbxw7 silencing was due to accumulation of core pluripotency
factors. However, depletion of Fbxw7 did not lead to stabilization
of Nanog, Oct4, or Sox2 (Figure 6A). Moreover, none of these
factors coimmunoprecipitated with Fbxw7 (Figure 6B). Fbxw7
has been shown to ubiquitinate a number of substrates,
including mTor, Notch, p100, Cyclin E, Klf5, cJun, Srebp,
Mcl-1, and c-Myc (Busino et al., 2012; Crusio et al., 2010;
Welcker et al., 2004; Ye et al., 2004). c-Myc is an essential regu-
lator of ESC self-renewal and cellular reprogramming (Cartwright
et al., 2005; Takahashi and Yamanaka, 2006) and is downregu-
lated during differentiation, whereas Fbxw7 is upregulated at
the transcriptional level as ESCs differentiate (Figure 6C). Ubiq-
uitination of c-Myc was detected in ESCs in the mass-spectrom-
etry experiments illustrated in Figure 1, and ubiquitination (as
well as phosphorylation) sites were identified (Figures 1A and
S3). Also, during differentiation c-Myc accumulated upon pro-
teasome inhibition (Figure 6D). Using shRNAs to silence
Fbxw7, we evaluated accumulation of known substrates, in-
cluding c-Myc, during ESC differentiation. These studies dem-
onstrated that upon Fbxw7 silencing only c-Myc protein levels
increased and remained equivalent to self-renewing ESCs
(Figures 6E–6G). We next sought to determine whether the inhi-
bition of the ESC differentiation phenotype resulting from Fbxw7
silencing could be rescued by decreasing c-Myc protein levels.
Using the Nanog-GFP reporter cell line and a gene-knockdown
combination, we were able to show that c-Myc loss was indeed
able to efficiently rescue Fbxw7-induced inhibition of the differ-
entiation phenotype (Figure 6H). Moreover, it was shown that
degradation of c-Myc is preceded by a phosphorylation on
threonine 58 (T58) by GSK3b (Gregory et al., 2003). To further
correlate Fbxw7 silencing to c-Myc stability, we used an ESC
line that, in the presence of 4-hydroxytamoxifen (4-OHT), ex-
presses a form of c-Myc with a mutation in the T58 phosphoryla-
tion site (c-MycT58AER ESCs) (Cartwright et al., 2005). During
differentiation in the absence of 4-OHT, c-Myc protein levels
are reduced, and cell morphology and SSEA1 expression are
consistent with differentiation, whereas in either the presence
of 4-OHT or the depletion of Fbxw7 cells, c-Myc levels are main-
tained and cells maintain an ESC morphology and SSEA-1
expression (Figures 6I–6K). Silencing of Fbxw7 further enhances
inhibition of differentiation in c-MycT58AER ESCs, suggesting
that it leads to accumulation of endogenous expressed c-Myc
combined with mutant c-MycT58A (Figures 6I–6K). These studies
identify Fbxw7 as a key regulator of ESC differentiation and
demonstrate that c-Myc is its key substrate in ESCs.(I–K) Following depletion of Fbxw7 with shRNA, MycT58AER ESCs were differentia
analyzed by (I) immunoblot for c-Myc, (J) SSEA1 expression, and (K) morpho
experiment (n = 2).
Data are represented as ± SEM; n = 3. *p value < 0.05; **p value < 0.01.
CellTheUPSMembersPsmd14andFbxw7HaveKeyRoles in
Cellular Reprogramming
Based on our previous studies, we have hypothesized that
Psmd14 and Fbxw7 could also play significant, although
opposing, roles in cellular reprogramming. We first saw that
Psmd14 is expressed significantly more highly at the messenger
RNA (mRNA) and protein level in both ESCs and iPSCs
compared to murine embryonic fibroblasts (MEFs) (Figure S7).
On the other hand, Fbxw7 expression was similar in all three
populations (Figure S7). We took advantage of a reprogram-
mable mouse model to determine the effect of silencing
Psmd14 and Fbxw7 on iPSC generation using siRNAs (Stadtfeld
et al., 2010). These animals carry a Dox-inducible polycistronic
cassette encoding the four reprogramming factors Oct4, Klf4,
Sox2, and c-Myc (OKSM) downstream of the collagen type I,
alpha 1 gene (Col1a1) and a reverse tetracycline transactivator
(rtTA) in the constitutively active ROSA26 locus. Using previously
validated siRNAs against Psmd14 and Fbxw7 (Figures 3D
and 4D), we silenced expression in ‘‘reprogrammable’’ MEFs
at different time points. MEFs were cultured in ESC media
containing Dox for 10 days, at which point media was changed
to ESC media without Dox. Six days after the transfection,
cells were transfected a second time with siRNA. At this time
point, morphology changes consistent with ongoing repro-
gramming were observed following silencing of Fbxw7; how-
ever, Psmd14-silenced MEFs maintained a fibroblast-like
morphology (Figure 7A). At day 14 MEFs treated with siRNA
against Fbxw7 produced 60% more ESC-like AP+ colonies
compared to MEFs treated with Dox alone (n = 3, p < 0.01). On
the other hand, knockdown of Psmd14 led to significant re-
duction in iPSC colony formation (n = 3, p = 0.01) (Figures
7B–7D). These studies suggested that silencing of Fbxw7
enhances iPSC generation and that the expression of the self-
renewal regulator Psmd14 is absolutely essential for cellular
reprogramming.
To further evaluate the effects of stable silencing of UPS
components on iPSC formation, OKSM MEFs were transduced
with virus-expressing shRNAs against either nontarget control,
Psmd14, or Fbxw7 (Figure S7). MEFs were sorted by GFP
expression and plated on wild-type mitomycin-C-treated MEF
feeder layer. MEFs expressing Psmd14 shRNAs failed to repro-
gram and generate iPSCs (Figures 7E and 7F). This data strongly
suggested that Psmd14 is required for iPSC generation. Once
more, the absence of shPsmd14+ iPSC colonies was not due
to a general effect on cell viability, as shPsmd14+ MEFs were
readily detectable (Figures 7F and S7). This finding was consis-
tent with the requirement of the full function of the proteasome
for inducing pluripotency, and even partial inhibition with a low
dose of MG132 completely inhibits reprogramming (Figure S7).
In agreement with the experiments using siRNA, Fbxw7 knock-
down promoted a 2-fold increase in cellular reprogramming effi-
ciency (Figure 7E). iPSC colonies derived from MEFs expressing
shRNA against Fbxw7 express pluripotency genes Nanog andted for 2 days (–LIF + 5 mMRA) without or in the presence of 10 nM 4-OHT and
logy of colonies. Bar graph represents MFI of SSEA1 in one representative
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Figure 7. Psmd14 and Fbxw7 Regulate Cellular Reprogramming
(A) Images of ubiquitously expressed actin-RFP 6 days post siRNA transfection and Dox (OKSM) induction demonstrating morphology changes.
(B) AP+ ESC-like colony count at day 14 following siRNA knockdown of Fbxw7 and Psmd14 relative to +Dox control.
(C) Absolute number of AP+ ESC-like colonies at day 14 after siRNA transfection and addition of Dox of MEFs. One representative experiment is shown (n = 4).
(D) AP staining 14 days after siRNA transfection and addition of Dox.
(E) Reprogramming efficiency of OKSM MEFs expressing shRNAs against nontarget, Psmd14, or Fbxw7 to generate AP+ ESC-like colonies. Colonies were
enumerated at day 14.
(F) Morphology of representative colonies following transduction of miRNA-adapted shRNA (shRNAmir) at day 14. Green, shRNAmir-transduced cells.
(G) Efficiency of OSK MEFs expressing shRNAs against nontarget or Fbxw7 to generate AP+ ESC-like colonies. Colonies were enumerated at day 14.
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state (Figure S7 and data not shown).
Because our previous studies identified c-Myc as a substrate
responsible for inhibition of differentiation following Fbxw7
silencing, we next asked whether Fbxw7 silencing could replace
exogenous c-Myc expression. Although exogenous expression
of Oct4, Sox2, Klf4, and c-Myc together induces reprogram-
ming, exogenous c-Myc can be omitted during reprogramming,
leading however to low reprogramming efficiency (Takahashi
and Yamanaka, 2006). We thus determined whether silencing
of Fbxw7 could augment reprogramming of MEFs that carry
a Dox-inducible polycistronic cassette encoding the three
reprogramming factors Oct4, Klf4, and Sox2 (OKS) (E.A. and
K.H., unpublished data). Silencing of Fbxw7 in OKS MEFs
significantly enhanced efficiency from 0.01% to 0.15%,
implicating Fbxw7 once more in the regulation of endogenous
c-Myc protein abundance (Figure 7G). Together, these studies
identified Psmd14 and Fbxw7 as regulators of cellular
reprogramming.
Comparing ESC and iPSC ‘‘Ubiproteomes’’
Although ESCs and iPSCs are highly similar with respect to their
morphology, behavior in culture, and developmental potential,
several lines of evidence point toward important molecular and
functional differences between these two pluripotent cell types
(Stadtfeld and Hochedlinger, 2010). We therefore decided to
study the iPSC ‘‘ubiproteome’’ in a similar fashion as illustrated
in Figure 1. Initially, we cross-referenced the ubiquitin-modified
proteins identified in iPSCswith previously published large-scale
protein expression analyses of iPSCs and MEFs (Huang et al.,
2012) and found that 112 of the proteins highly expressed in
iPSCs compared to MEFs were ubiquitinated (Figure 7H).
Then, we compared the ubiquitin-modified proteins identified
in pluripotent ESCs and iPSCs and found an overlap of 65.7%
(992 proteins) between both populations (Figures 7I and S7;
Table S7). Interestingly, out of these 992 ubiquitin-modified
proteins, 25% were exclusively ubiquitinated in ESCs and
iPSCs, but not in MEFs. Among the shared ubiquitinated
proteins, we identified the majority of the pluripotency network
proteins (Figure 7J). Our combined studies revealed that the
UPS participates in the regulation of the complex process of
cellular reprogramming and that both ESCs and iPSCs use ubiq-
uitination in similar ways to regulate the abundance and activity
of key factors of pluripotency.
DISCUSSION
This study identifies the UPS as an additional level of regulation
of pluripotency and cellular reprogramming. Our work maps the
ESC ‘‘ubiproteome,’’ and identifies a substantial amount of ubiq-
uitinated proteins with important roles during ESCdifferentiation.(H) Proteins identified and quantified in MEFs and iPSCs in previous studies, sho
ubiquitinated.
(I) Overlap between ubiquitinated proteins in ESC and iPSC and comparison wit
(J) Self-renewal network, as depicted in Figure 1D, demonstrating proteins that
ubiquitinated in MEFs are marked in yellow. Proteins in orange were found ubiq
iPSCs.
Data are represented as ± SEM; n = 3. *p value < 0.05; **p value < 0.01.
CellMoreover, using UPS-targeted RNAi screens, we have identified
a significant number of ubiquitin enzymes essential for the regu-
lation of pluripotency, ESC differentiation, and homeostasis.
These genes are both ubiquitin ligases and deubiquitinases,
suggesting that both modes of regulation could be important
for ESC function. We have focused on the function of Psmd14
and shown that this DUB is a part of the 19S proteasome lid,
its expression is regulated during ESC differentiation, and its
silencing affected ESC pluripotency and abrogated cellular
reprogramming. Additionally, we have studied a role of the ligase
Fbxw7 in ESC differentiation and induced pluripotency and have
identified c-Myc (within a large number of described substrates)
as one of the key ubiquitinated protein substrates of Fbxw7
involved in ESC differentiation. Finally, we have identified addi-
tional roles for UPS members in cellular reprogramming, along
with characterizing the ‘‘ubiproteome’’ of fully reprogrammed
somatic cells.
Our mass-spectrometry-based mapping of the ESC and iPSC
‘‘ubiproteome’’ demonstrated that a significant number of
known components of the ESC pluripotency network, including
members of the Nanog and Oct4 pathways, are ubiquitinated.
A few of them, including Nanog, c-Myc, and Oct4, have been
previously suggested to be regulated by ubiquitination (Liao
and Jin, 2010; Ramakrishna et al., 2011); however, there was
little information on their sites of ubiquitination and the role of
such ubiquitination events in ESC pluripotency and differentia-
tion. Moreover, our studies also identified sites of ubiquitination
on additional known regulators of pluripotency (e.g., Setdb1,
Jarid2, and Fbxo15). These combined observations introduce
the hypothesis that ubiquitin-mediated fine-tuning of the abun-
dance of essential pluripotency regulators could support distinct
states of pluripotency or predispose the cell for the initiation of
a program of differentiation. Future studies will further detail
the role of UPS and assign novel ligases and DUBs to the
ESC-specific substrates.
Our studies have identified a large number of UPS members,
both ligases and deubiquitinases, that have essential roles in
both ESC self-renewal and differentiation. One of these proteins
is the E3 ligase Fbxw7, the depletion of which lead to inhibition
of differentiation and, more importantly, enhancement of iPSC
generation. c-Myc, one of the known Fbxw7 substrates, is
known to play key roles both in ESC homeostasis and in somatic
cell reprogramming (Smith et al., 2010; Takahashi and
Yamanaka, 2006). We were able to demonstrate that c-Myc
depletion rescues inhibition of differentiation induced by silenc-
ing of Fbxw7, suggesting that the majority of the ESC-specific
Fbxw7 activity passes through c-Myc. In agreement with our
findings, it was recently shown that self-renewing ESCs are char-
acterized by active Akt signaling, leading to GSK3 translocation
and inhibition of c-Myc phosphorylation (An et al., 2008), an
event that leads to Fbxw7 recruitment. Our data provide thewing proteins highly expressed in iPSCs and the number of the ones that are
h ubiquitinated proteins in MEFs.
have been identified to be ubiquitinated in iPSC and ESC (gray). Proteins also
uitinated in iPSCs and MEFs, and proteins in purple were exclusively found in
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degradation of c-Myc during ESC differentiation. However, we
cannot exclude the possibility that additional novel Fbxw7
substrates are also important for optimal ESC differentiation.
The DUB Psmd14 appears to be necessary for the mainte-
nance of ESC pluripotency. Our proteomic analysis revealed
striking Psmd14 specificity for the 19S proteasome lid, in agree-
ment with recent positional mapping of the yeast proteasome
(Lander et al., 2012), suggesting that the structure of the
mammalian proteasome lid adopts similar conformation. We
have utilized mutagenesis of the Psmd14 active site and
concluded that the requirement for Psmd14 at the proteasome
lid is due to its specific DUB enzymatic activity. Indeed, a single
point mutation on the conserved zinc-coordinating histidine 113
abolished DUB activity. These results are in agreement with
mutational studies on Psmd14 function in human protein ortho-
logs (Gallery et al., 2007). In contrast, we found cysteine 120 to
be dispensable for Psmd14 function in ESCs, consistent with
the fact that it belongs to a family distinct from the cysteine
proteases. These results suggested that Psmd14 plays a crucial
role in maintaining self-renewal and pluripotency by controlling
deubiquitination, a key step in protein degradation. We suggest
that active ubiquitination (and deubiquitination) and protein
degradation are required for proper maintenance of pluripotency
for two main reasons: for maintaining the expression threshold
for members of the pluripotency network (i.e., Nanog and
Oct4) and for counteracting permissive expression of factors
that could favor differentiation. Supporting this notion, Dillin
and colleagues have recently identified that expression and
function of PSMD11, an interacting partner of PSMD14, is essen-
tial for human ESC pluripotency (Vilchez et al., 2012).
Recent systems-biology-level studies suggested the exis-
tence of additional modes of regulation, responsible for changes
in protein expression levels, controlling ESC fate and homeo-
stasis (Lu et al., 2009). Our study identifies the UPS as such
a layer of regulation and suggests that dynamic ubiquitin tagging
could be essential for physiological ESC differentiation and early
embryogenesis. The dynamic reversibility of the ubiquitin modi-
fication and the recent development of both general proteasome
inhibitors (Adams and Kauffman, 2004) as well as specific antag-
onists of ligase function (Aghajan et al., 2010; Orlicky et al., 2010)
open the way for future manipulation of the UPS in ESCs leading
to more efficient induced pluripotency (iPSC generation) and
targeted differentiation toward predetermined lineages.
EXPERIMENTAL PROCEDURES
Isolation of Ubiquitinated Peptides and Mass Spectrometry
For SILAC experiments, undifferentiated ESCs were labeled with 13C6
15N4-
arginine and 13C6-lysine for five or more passages and treated with MG132.
Cells were kept undifferentiated and were subjected to differentiation in the
presence of 5 mM RA. Equal amounts of proteins of both populations were
mixed and lysed together, and the resulting protein extracts were reduced,
carboxamidomethylated, and digested with trypsin. Peptides were separated
from nonpeptide material by solid-phase extraction with Sep-Pak C18
cartridges. Lyophilized peptides were redissolved, and peptides with the
K-GGmodification were purified using the K-GGmotif antibody (Cell Signaling)
conjugated to Protein A Agarose (Roche). Eluted peptides were desalted and
concentrated with PerfectPure C18 tips immediately prior to LC-MS/MS anal-
ysis. Tandem mass spectra were collected with an LTQ Orbitrap hybrid mass
spectrometer. For the label-free samples, we used cells of each population796 Cell Stem Cell 11, 783–798, December 7, 2012 ª2012 Elsevier Inindependently and analyzed them with the same methodology. Further details
concerning label-free quantification of K-GG-modified peptides can be found
in the Supplemental Experimental Procedures.
ESC Culture, Transfection, and Alkaline Phosphatase Staining
ESC lines were maintained on gelatin-coated plates in ESC media as
described previoulsy (Reavie et al., 2010). For the self-renewal screen,
Nanog-GFP ESCs (kind gift from Dr. I. Lemischka, Mount Sinai School of
Medicine) were transfectedwith 30 nM siRNA (Dharmacon). For differentiation,
12 hr post transfection, ESCmedia was changed tomedia without LIF that also
contained 5 mM RA. GFP fluorescence was measured using an LSR II (BD
Biosciences) 48–72 hr post transfection. C-MycT58AER ESCs were maintained
in ESC media supplemented with 10 nM 4-OHT (kind gift from Dr. Stephen
Dalton, University of Georgia). For alkaline phosphatase staining, assays cells
were fixed and stained with an alkaline phosphatase detection kit (Millipore).
Cloning in Targeting Vectors and Engineering of ESCs Expressing
Tagged Proteins
Complementary DNAs (cDNAs) for Psmd14WT, Psmd14H113Q, Psmd14C120S,
and eGFP were cloned in frame into the modified and Tet-operated vector
pINTA, bearing N-terminal Strep-TagII/Flag (SF) tandem tags (Gloeckner
et al., 2009) (kind gift of Dr. R. Bonasio, NYU School of Medicine). The resulting
vectors were nucleoporatated (Amaxa) into KH2 ESCs engineered to carry an
M2rtTA transactivator in the ROSA26 locus, ensuring inducible expression of
the tagged cDNA(Beard et al., 2006; Hochedlinger et al., 2005). ESCs were
selected with 50 mg/ml Zeocin (Invitrogen) for 7 days. Expression of tagged
proteins was confirmed by western blot analysis with StrepTagII antibody
(StrepMAB-Classic, IBA).
Flow Cytometry Analysis
For intracellular c-Myc staining, cells trypsinized, fixed, and permeabilized
using the BD Cytofix/Cytoperm kit following the manufacturer’s protocol.
Stainings were performed with rabbit anti-c-Myc (Cell Signaling) followed by
goat anti-rabbit Alexa Fluor 647 (Invitrogen).
Immunofluorescence
siRNA transfections were carried out in 96-well black plates (Corning).
Cells were fixed with 4% paraformelhyde (BD Biosciences) for 10 min and
permeabilized for 10 min using 0.1% Triton X-100 (Sigma-Aldrich). Wells
were blocked with 3% goat serum (Invitrogen) and stained with primary
antibodies overnight for Ubiquitin Lys48-specific (Apu2) (Millipore) and
Oct-3/4 (C-10) (Santa Cruz). Secondary antibody staining was performed
with Alexa488- or 594-conjugated antibodies (Invitrogen), Alexa594-conju-
gated Phalloidin (Invitrogen), and DAPI.
Microarray Analysis
Total cellular RNA was isolated using the RNeasy microkit (QIAGEN) using the
manufacturer’s instructions. Following cDNA synthesis and labeling, samples
were hybridized to Affymetrix mouse 430 chips and scanned at the NYU
Genomics Core. CEL files were loaded into GeneSpring (Agilent) for assess-
ment of overall quality. Feature intensities for each probe set were condensed
into a single intensity value using the Microarray Suite 5.0 algorithm.
Cellular Reprogramming
For siRNA silencing during reprogramming, ‘‘reprogrammable’’ MEFs were
reverse transfected with 30 nM siRNA (Dharmacon) and lipofectamine 2000
(Invitrogen) in a 12-well plate; the following day, media was replaced with
ESC media and 2 mg/ml Dox (Stadtfeld et al., 2010). Seven days after initial
transfection, cells were transfected a second time and day 11 Dox was
removed, and cells were cultured in ESC media until day 15 post transfection.
ESC-like colonies were enumerated and stained for alkaline phosphatase
activity (Millipore). For experiments with shRNA silencing, reprogrammable
MEFs were plated with concentrated pLMP-GFP retrovirus in the presence
of 8 mg/ml polybrene. The following day, GFP+ cells were sorted and plated
on mitomycin-C-treated MEFs, media was replaced with ESC media con-
taining 2 mg/ml Dox and replaced every other day for 10 days, and Dox was
removed for the last 4 days of the cultures. At day 14, ESC-like colonies
were enumerated and/or clones were isolated.c.
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All experiments were performed in triplicate unless otherwise noted, and
statistical analyses were performed using paired two-tailed Student’s t test
assuming experimental samples of equal variance. *p value < 0.05; **p value <
0.01. siRNA libraries were divided into seven 96-well plates, each containing
negative and positive controls, as well as nontarget control. The Z score
(Z = [x  m]O s) was determined for each plate, where x is the raw score to
be standardized, m is the mean of the differential expression (% differential
expression = % GFP+ cells in target gene  % GFP+ in nontarget control) of
the plate, and s is the SD of the plate. Each plate was performed in triplicate,
and the Z score was averaged between triplicate experiments.
ACCESSION NUMBERS
All microarray data are deposited in the Gene Expression Omnibus (GEO)
database with accession number GSE39772.
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